I am a
Home I AM A Search Login

Papers of the Week


2022 Mar 31


J Infect Dev Ctries


16


3

Pulmonary aspergilloma in immunocompromised patients in a Respiratory Care Unit.

Authors

Hernández-Solís A, Álvarez-Maldonado P, Araiza-Santibáñez J, Cruz-Muñoz K, Cícero-Sabido R, Quintana Martínez A
J Infect Dev Ctries. 2022 Mar 31; 16(3):564-569.
PMID: 35404864.

Abstract

Pulmonary aspergilloma is commonly associated with comorbidities that cause immunodeficiency such as diabetes mellitus, tuberculosis, human immunodeficiency virus/acquired immunodeficiency syndrome and/or a pre-existing parenchymal lung disease such as chronic obstructive pulmonary disease. Predisposing factors can further increase the risk of acquiring this mycosis. Our objective was to determine the frequency, clinical and microbiological characteristics of pulmonary aspergilloma in immunocompromised patients.